PATENT CLAIM ANALYSIS

Application Number: 15741996
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-11
Patent Classification: ["514", "04400A"]

Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting DGAT2 expression, which may be useful for treating, preventing, or ameliorating a disease associated with DGAT2.

Claim (Index 34):
A compound consisting of a modified oligonucleotide consisting of 20 linked nucleosides having a nucleobase sequence consisting of the sequence recited in SEQ ID NO: 1423, wherein the modified oligonucleotide comprises a gap segment consisting of ten linked 2\u2032-deoxynucleosides;\n a 5\u2032 wing segment consisting of five linked nucleosides; and a 3\u2032 wing segment consisting of five linked nucleosides; wherein the gap segment is positioned between the 5\u2032 wing segment and the 3\u2032 wing segment, wherein each nucleoside of each wing segment comprises a 2\u2032-O-methoxyethyl sugar; wherein each internucleoside linkage is a phosphorothioate linkage and wherein each cytosine is a 5-methylcytosine.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 86.0
- Lexical Diversity: 1.26923
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14050574', '14854281', '13660885', '13623337', '14959714']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.836081077253648
- 35 USC 102 Novelty (BERT): 0.5189571425642534
- Combined Prediction Score: 0.8043686837847086
- Mean Citation Score: 336.2592820000001
- Max Citation Score: 342.58948
- Similarity Product: 325.96129063665387

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test